|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Kymera Therapeutics, Inc. (KYMR) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
74,207,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kymera Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s proprietary targeted protein degradation platform, which Co. refers to as Pegasus™, allows Co. to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Co. has utilized its Pegasus™ platform to design protein degraders focused in the areas of immunology-inflammation and oncology, and Co. continues to apply its platform's capabilities to additional therapeutic areas.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
1 |
414,106 |
| Total Buy Value |
$0 |
$0 |
$46 |
$5,301,371 |
| Total People Bought |
0 |
0 |
1 |
2 |
| Total Buy Transactions |
0 |
0 |
1 |
3 |
| Total Shares Sold |
60,424 |
79,952 |
594,512 |
1,538,894 |
| Total Sell Value |
$2,879,923 |
$3,509,925 |
$23,679,762 |
$62,489,302 |
| Total People Sold |
5 |
8 |
9 |
11 |
| Total Sell Transactions |
6 |
11 |
17 |
40 |
| End Date |
2025-03-16 |
2024-12-13 |
2024-06-14 |
2023-06-15 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Ridloff Elena |
|
– • – |
2025-06-11 |
4 |
AS |
$50.00 |
$225,000 |
D/D |
(4,500) |
0 |
|
- |
|
| Ridloff Elena |
|
– • – |
2025-06-11 |
4 |
OE |
$20.29 |
$91,305 |
D/D |
4,500 |
4,500 |
|
- |
|
| Ridloff Elena |
|
– • – |
2025-06-03 |
4 |
AS |
$45.50 |
$553,200 |
D/D |
(12,000) |
0 |
|
- |
|
| Ridloff Elena |
|
– • – |
2025-06-03 |
4 |
OE |
$27.67 |
$332,040 |
D/D |
12,000 |
12,000 |
|
- |
|
| Mainolfi Nello |
Chief Executive Officer |
• • – |
2025-06-03 |
4 |
AS |
$49.00 |
$1,470,000 |
D/D |
(30,000) |
660,482 |
|
- |
|
| Mainolfi Nello |
Chief Executive Officer |
• • – |
2025-06-03 |
4 |
OE |
$2.08 |
$62,400 |
D/D |
30,000 |
690,482 |
|
- |
|
| Albers Jeffrey W. |
|
– • – |
2025-06-03 |
4 |
AS |
$49.00 |
$311,101 |
D/D |
(6,349) |
0 |
|
- |
|
| Albers Jeffrey W. |
|
– • – |
2025-06-03 |
4 |
OE |
$10.34 |
$65,649 |
D/D |
6,349 |
6,349 |
|
- |
|
| Esposito Pamela |
|
– • – |
2025-06-03 |
4 |
AS |
$49.04 |
$245,186 |
D/D |
(5,000) |
0 |
|
- |
|
| Esposito Pamela |
|
– • – |
2025-06-03 |
4 |
OE |
$29.55 |
$147,750 |
D/D |
5,000 |
5,000 |
|
- |
|
| Chadwick Jeremy G |
Chief Operating Officer |
• – – |
2025-05-23 |
4 |
S |
$29.30 |
$75,436 |
D/D |
(2,575) |
66,420 |
|
- |
|
| Goodman Noah |
Chief Business Officer |
• – – |
2025-04-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
81 |
|
- |
|
| Goodman Noah |
Chief Business Officer |
• – – |
2025-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,081 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2025-03-31 |
4 |
OE |
$2.08 |
$52,000 |
D/D |
25,000 |
226,886 |
|
- |
|
| Chiniara Ellen |
Chief Legal Officer |
• – – |
2025-03-03 |
4 |
S |
$30.33 |
$68,239 |
D/D |
(2,241) |
80,085 |
|
- |
|
| Chiniara Ellen |
Chief Legal Officer |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
27,500 |
82,326 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2025-03-03 |
4 |
S |
$30.33 |
$214,219 |
D/D |
(7,035) |
201,886 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
208,921 |
|
- |
|
| Chadwick Jeremy G |
Chief Operating Officer |
• – – |
2025-03-03 |
4 |
S |
$30.33 |
$42,113 |
D/D |
(1,383) |
67,800 |
|
- |
|
| Chadwick Jeremy G |
Chief Operating Officer |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
69,183 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2025-03-03 |
4 |
S |
$30.33 |
$174,786 |
D/D |
(5,740) |
120,000 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
30,000 |
125,740 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2025-01-10 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
178,921 |
|
- |
|
| Mainolfi Nello |
Chief Executive Officer |
• • – |
2025-01-10 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
659,959 |
|
- |
|
| Chiniara Ellen |
Chief Legal Officer |
• – – |
2025-01-06 |
4 |
S |
$41.75 |
$130,645 |
D/D |
(3,129) |
54,826 |
|
- |
|
249 Records found
|
|
Page 1 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
